Guangzhou Maxinovel Pharmaceuticals Co., Ltd.

Chine

Commandez votre montre hebdomadaire Guangzhou Maxinovel Pharmaceuticals Co., Ltd.
Quantité totale PI 34
Rang # Quantité totale PI 42 836
Note d'activité PI 2,3/5.0    24
Rang # Activité PI 32 919

Brevets

Marques

14 0
4 0
16 0
0
 
Dernier brevet 2024 - Pharmaceutical composition of pd...
Premier brevet 2014 - Five-and-six-membered heterocycl...

Derniers inventions, produits et services

2024 Invention Pharmaceutical composition of pd-l1 small-molecule inhibitor and antibody, and use thereof. Discl...
2023 Invention Crystal form of five-membered and six-membered heterocyclic compound, preparation method therefor...
Invention Use of fused ring pyrimidine compound. Disclosed is use of a fused ring pyrimidine compound or a ...
Invention Thienopyrimidine compound, intermediate, and preparation method therefor, composition thereof and...
2022 Invention Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceu...
2021 Invention Screening method for fgfr inhibitor. A screening method for an FGFR inhibitor: 1) respectively ap...
Invention Aromatic ethylene compound and preparation method therefor, and intermediate, pharmaceutical comp...
Invention Novel therapeutic methods. The disclosure provides new therapeutic uses for certain fused ring p...
Invention Novel therapeutic methods. Provided herein are new therapeutic uses for certain fused ring pyrimi...
Invention Crystal form of aromatic vinyl derivatives, and preparation method therefor and use thereof. Disc...
Invention Thienopyrimidine derivative and preparation method therefor. Disclosed are a thienopyrimidine de...
Invention Thienopyrimidine derivative and preparation method therefor. Disclosed are a thienopyrimidine der...
2020 Invention Combination of small molecule inhibitor of the pd-1/pd-l1 interaction and anti-pd-1 antibody for ...
Invention Small molecule inhibitors for treating cancer in a subject having tumors with high interstitial p...
Invention Small-molecule inhibitor of pd-1/pd-l1, pharmaceutical composition thereof with pd-l1 antibody, a...
2019 Invention Salt of fused ring pyrimidine compound, crystal form thereof and preparation method therefor and ...
Invention Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmace...
2018 Invention Aminopyrimidine five-membered heterocyclic compound, and intermediate, preparation method, pharma...
2017 Invention Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutica...
2016 Invention Fused ring pyrimidine compound, intermediate, and preparation method, composition and use thereof...
2014 Invention Five-and-six-membered heterocyclic compound, and preparation method, pharmaceutical composition a...